Schistosomiasis is a parasitic infection caused by blood flukes (Schistosoma species) transmitted through contact with contaminated water. The disease affects populations with inadequate water and sanitation infrastructure, particularly in regions with endemic freshwater snail vectors. Two species cause human disease in Kenya: Schistosoma mansoni (causing intestinal disease) and Schistosoma haematobium (causing urinary disease). Infection causes chronic inflammation, anemia, malnutrition, and in severe cases, organ damage and disability. Children are disproportionately affected, with infection affecting school attendance and cognitive development. Geographic distribution follows water sources including Lake Victoria, rivers, and small water bodies used for swimming and water collection.
Kenya's schistosomiasis control programs emphasize mass drug administration (MDA) targeting school-age children in endemic areas, the population group with highest infection prevalence and most benefit from treatment. Praziquantel is the first-line anthelmintic drug, effective against both Schistosoma species, provided through school-based distribution campaigns. Regular MDA campaigns reduce infection intensity and prevalence, preventing complications and reducing morbidity. Health education programs promote awareness of transmission prevention including avoiding contact with contaminated water and proper water treatment.
Water and sanitation improvements reduce schistosomiasis transmission by eliminating human fecal contamination of water sources and reducing snail habitat. Providing safe water sources enables families to avoid contaminated water for drinking and washing. Improved sanitation facilities reduce transmission of infection to water sources. However, behavioral change limiting water contact for swimming and bathing is difficult to achieve, particularly among children. Combined approaches integrating MDA, water and sanitation improvements, and health education provide most effective schistosomiasis control.
Snail surveillance and control programs monitor vector distribution and implement targeted interventions in areas with high snail populations. Chemical molluscicides, environmental modifications reducing snail habitat, and biological control approaches have been evaluated. However, limited resources constrain comprehensive snail control implementation, and drug treatment remains the primary intervention. Monitoring treatment effectiveness and surveillance for drug resistance ensure program effectiveness, though resistance has not yet emerged as a major concern in Kenya.
Kenya's schistosomiasis control programs have achieved reductions in infection prevalence and intensity in endemic areas through sustained MDA campaigns. However, elimination of transmission requires complete interruption of parasite lifecycle through combined water and sanitation investments and continued drug treatment. Continued investment in school-based MDA, water and sanitation infrastructure, and population monitoring remain necessary for achieving schistosomiasis elimination.
See Also
Water Sanitation Health Child Health Pediatric Care Disease Surveillance Kenya Rural Healthcare Access Parasitic Diseases Kenya Poverty